Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Non-cash Items: 2020-2023

Historic Non-cash Items for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $23.2 million.

  • Therapeutics' Non-cash Items fell 99.95% to $3,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $3,000, marking a year-over-year decrease of 99.95%. This contributed to the annual value of $23.2 million for FY2023, which is 146.22% up from last year.
  • As of FY2023, Therapeutics' Non-cash Items stood at $23.2 million, which was up 146.22% from $9.4 million recorded in FY2022.
  • In the past 5 years, Therapeutics' Non-cash Items ranged from a high of $38.4 million in FY2021 and a low of $9.4 million during FY2022.
  • For the 3-year period, Therapeutics' Non-cash Items averaged around $23.7 million, with its median value being $23.2 million (2023).
  • In the last 5 years, Therapeutics' Non-cash Items surged by 245.38% in 2021 and then slumped by 75.47% in 2022.
  • Therapeutics' Non-cash Items (Yearly) stood at $11.1 million in 2020, then surged by 245.38% to $38.4 million in 2021, then slumped by 75.47% to $9.4 million in 2022, then skyrocketed by 146.22% to $23.2 million in 2023.